Last reviewed · How we verify
Acellular system
At a glance
| Generic name | Acellular system |
|---|---|
| Sponsor | Universidad de los Andes, Chile |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy (NA)
- Acellular Matrix From Human Dermis in Combination With Orthobiologic Stimuli for Augmentation of Massive Rotator Cuff Tears (NA)
- Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular System Injuries
- Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma (PHASE1)
- Encapsulated Acellular System From Mesenchymal Stem Cells for Dental Pulp Regeneration (PHASE1)
- Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems (PHASE1)
- Prevention of Seroma Formation and Wound Complications Using NPWT Devices (NA)
- The Influence of Mucosal Tissue Thickness on Soft and Hard Tissue Changes Around Implants (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |